Biopharma Reports Fifth Quarter of Increased Net Revenues
15 Mayo 2023 - 10:40AM
AllPennyStocks.com
Those afflicted with sickle cell disease face many challenges
and acute complications. This biopharma company is the leader in
treatment of the disease and just reported its fifth straight
increase...
To read the full story on AllPennyStocks.com, click
here.
Emmaus Life Sciences (NASDAQ:EMMA)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Emmaus Life Sciences (NASDAQ:EMMA)
Gráfica de Acción Histórica
De May 2023 a May 2024